8225 — China Health Cashflow Statement
0.000.00%
Last trade - 00:00- HK$147.31m
- HK$129.72m
- CNY26.45m
- 40
- 19
- 60
- 32
Annual cashflow statement for China Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 70.8 | 42.5 | -15.8 | -58.2 | -14.5 |
| Depreciation | |||||
| Non-Cash Items | -15.7 | 0.139 | 9.78 | 59.3 | 16.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -36.3 | -53.1 | 0.74 | -0.234 | 7.68 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 19.1 | -10.3 | -5.16 | 1.12 | 10.3 |
| Capital Expenditures | 0 | — | — | -6 | -1.76 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -12 | 6.96 | -2.15 | 4.96 | 1.53 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12 | 6.96 | -2.15 | -1.04 | -0.23 |
| Financing Cash Flow Items | -0.061 | -0.015 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.593 | -1.51 | 0 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.73 | -4.83 | -7.3 | 0.08 | 10.1 |